Cr-ACP1

General Information


DRACP ID  DRACP00316

Peptide Name   Cr-ACP1

Sequence  AWKLFDDGV

Sequence Length  9

UniProt ID  B3EWE7 

PubChem CID  Not available

Origin  Cycas revoluta seeds

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HEp-2 Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=1.5 mM MTT assay 72 h 1
HCT 15 Colon adenocarcinoma Carcinoma IC50=0.8 mM MTT assay 72 h 1

Hemolytic Activity  Human erythrocytes: 5% Hemolysis=1 mM

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50>4 mM

Target  DNA

Affinity  Not available

Mechanism  Proapoptosis

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00316

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C50H71N11O14

Absent amino acids  CEHIMNPQRSTY

Common amino acids  D

Mass  119307

Pl  4.11

Basic residues  1

Acidic residues  2

Hydrophobic residues  5

Net charge  -1

Boman Index  -597

Hydrophobicity  4.44

Aliphatic Index  86.67

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  687.5

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21882228

Title  Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties

Doi 10.1002/jcb.23343

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3238

DRACP is developed by Dr.Zheng's team.